CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis

The long-term use of psychopharmacology medications in autism spectrum disorder (ASD) hitherto remains controversial due to a lack of evidence about safety and tolerability. In this regard, genotyping the metabolizing enzyme cytochrome P450 (CYP) 2D6, especially its extreme phenotypes, could help to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballester, Pura, Espadas, Cristina, Almenara, Susana, Barrachina, Jordi, Muriel, Javier, Ramos, Enrique, Toral, Natalia, Belda, César, Peiró, Ana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385457/
https://www.ncbi.nlm.nih.gov/pubmed/37513866
http://dx.doi.org/10.3390/ph16070954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385457/
https://www.ncbi.nlm.nih.gov/pubmed/37513866
http://dx.doi.org/10.3390/ph16070954

Ejemplares similares